# § 524.838   Esafoxolaner, eprinomectin, and praziquantel.

(a) *Specifications.* Each milliliter (mL) of topical solution contains 12 milligrams (mg) esafoxolaner, 4 mg eprinomectin, and 83 mg praziquantel.


(b) *Sponsor.* See No. 000010 in § 510.600(c) of this chapter.


(c) *Conditions of use*—(1) *Amount.* Administer the entire contents of a provided unit applicator topically once a month at a minimum dose of 0.055 mL/lb (0.12 mL/kg), which delivers a minimum dose of 0.66 mg/lb (1.45 mg/kg) esafoxolaner, 0.23 mg/lb (0.51 mg/kg) eprinomectin, and 4.55 mg/lb (10.0 mg/kg) praziquantel.


(2) *Indications for use.* For the prevention of heartworm disease caused by *Dirofilaria immitis.* Kills adult fleas (*Ctenocephalides felis*) and is indicated for the treatment and prevention of flea infestations, the treatment and control of *Ixodes scapularis* (black-legged tick) and *Amblyomma americanum* (lone star tick) infestations, and the treatment and control of roundworms (fourth-stage larval and adult *Toxocara cati*), hookworms (fourth-stage larval and adult *Ancylostoma tubaeforme;* adult *Ancylostoma braziliense*), and tapeworms (*Dipylidium caninum*) in cats and kittens 8 weeks of age and older, and weighing 1.8 lbs or greater.


(3) *Limitations.* Federal law restricts this drug to use by or on the order of a licensed veterinarian.



---

[N] [88 FR 55566, Aug. 16, 2023]






